Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

U.S. Fertility Diagnostic Innovation and Product Evolution

Date : 15 June 2026

Latest Updates of Key Players in the U.S. Fertility Diagnostic Market

U.S. Fertility Diagnostic Market Companies

Recent Developments in the U.S. Fertility Diagnostic Market

  • In June 2026, Vespexx Inc., a femtech organization building products around the science of dyadic health, announced the official U.S. launch of Soonr Health, a preconception health platform intended for couples who are trying to conceive.
  • In January 2026, U.S. Fertility, the nation’s largest collaboration of physician-owned fertility practices, announced that the Piedmont Reproductive Endocrinology Group (PREG) has combined its growing network of leading fertility practices and IVF laboratories.

Market Ecosystem Analysis

Ecosystem Segment Key Participants Role in Market
Technology Providers Illumina, Thermo Fisher Scientific, Revvity, Natera Supply sequencing, genomics, molecular diagnostics, and reproductive testing technologies
Product Manufacturers CooperSurgical, Femasys, FUJIFILM Irvine Scientific, Vitrolife Group Develop fertility diagnostic devices, reproductive health consumables, IVF-related diagnostic products
Service Providers Labcorp, Quest Diagnostics, Kindbody, CCRM Fertility Deliver fertility testing, laboratory diagnostics, and reproductive health services
Platform Providers Natera, Progyny, Ovia Health, Kindbody Digital fertility assessment, patient management, genetic testing platforms
CROs/CDMOs IQVIA, ICON plc, Charles River Laboratories Support fertility-related clinical research and reproductive health studies
Software Vendors Alife Health, Univfy, Ovia Health AI-assisted fertility analytics, IVF optimization, patient engagement platforms
Research Institutions Harvard Medical School, Johns Hopkins University, Stanford University, NIH Conduct fertility, reproductive medicine, and genetics research
End-User Industries Fertility Clinics, IVF Centers, Hospitals, Academic Medical Centers, Diagnostic Laboratories Primary consumers of fertility diagnostic solutions

Supply Chain Analysis

R&D:

  • Research and development services in the U.S. fertility diagnostic market include biomarker and assay development, sperm and andrology analysis, imaging and uterine evaluation technologies, digital health, and software integration 
  • Key Players: GE HealthCare and Koninklijke Philips N.V.

Manufacturing Processes:

  • Manufacturing processes include at-home fertility test kits, clinical and laboratory diagnostic equipment, consumables, and specialized tools.
  • Key Players: Samsung Healthcare and CooperSurgical, Inc.

Patient Services:

  • Major services involve initial consultation and physical exam, female diagnostic services, and male diagnostic services such as semen analysis and hormone testing.
  • Key Players: Femasys Inc. and Thomas Medical

Competitive Landscape

Tier 1
Company Name Headquarters Country Why Relevant to This Market Key Products/Services
CooperSurgical, Inc. Trumbull, Connecticut United States Leading fertility and reproductive health company with broad fertility diagnostics and IVF portfolio Fertility Solutions, Ovulation Tests, IVF Laboratory Products
Thermo Fisher Scientific Inc. Waltham, Massachusetts United States Major provider of reproductive genetics and molecular diagnostic technologies Genetic Testing Solutions, PCR Systems, NGS Platforms
Illumina, Inc. San Diego, California United States Dominant player in reproductive genomics and preimplantation genetic testing infrastructure NGS Systems, Reproductive Genomics Platforms
Labcorp Holdings Inc. Burlington, North Carolina United States Large fertility testing and reproductive diagnostic service provider Hormonal Testing, Fertility Panels, Genetic Screening
Quest Diagnostics Incorporated Secaucus, New Jersey United States Extensive nationwide fertility diagnostic testing network Fertility Hormone Testing, Reproductive Health Diagnostics
Tier 2
Company Name Headquarters Country Why Relevant to This Market Key Products/Services
Natera, Inc. Austin, Texas United States Leading reproductive genetic testing specialist Carrier Screening, Genetic Testing, Women's Health Diagnostics
Revvity, Inc. Waltham, Massachusetts United States Strong reproductive health and prenatal diagnostics portfolio Reproductive Screening, Genetic Testing Solutions
Vitrolife Group Gothenburg Sweden Major IVF and embryo assessment technology provider active in the U.S. market Embryo Evaluation, Time-Lapse Imaging, IVF Diagnostics
FUJIFILM Irvine Scientific Santa Ana, California United States Significant IVF laboratory solutions provider IVF Culture Media, Reproductive Laboratory Products
Kindbody, Inc. New York, New York United States Growing fertility services platform integrating diagnostics and care delivery Fertility Testing, IVF Diagnostics, Reproductive Care Services
Tier 3
Company Name Headquarters Country Why Relevant to This Market Key Products/Services
Femasys Inc. Suwanee, Georgia United States Specialized reproductive diagnostics innovator FemVue, FemCath, Fertility Evaluation Systems
Alife Health, Inc. San Francisco, California United States AI-focused fertility diagnostics and IVF optimization company AI Fertility Analytics Platform
Univfy Inc. Los Altos, California United States Predictive fertility analytics provider IVF Success Prediction Software
Ovia Health Boston, Massachusetts United States Digital fertility monitoring and reproductive health platform Fertility Tracking and Assessment Solutions
Inne (NaturalCycles GmbH) Berlin Germany Emerging fertility hormone monitoring technology company with U.S. presence Hormone-Based Fertility Monitoring Device

Market Growth

The U.S. fertility diagnostics market size was reported at US$ 1.42 billion in 2025 and is expected to rise to US$ 1.55 billion in 2026 to reach US$ 3.33 billion by 2035. According to forecasts, it will grow at a CAGR of 8.9%.

U.S. Fertility Diagnostic Market Size is USD 1.55 Billion in 2026.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales